Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6449919 | 0.85 | TET2 (0.34) | TET2 | |
| SCHEMBL450544 | 0.84 | MEN1 (0.32) | — | |
| SCHEMBL1135149 | 0.82 | TDP1 (0.36) | — | |
| SCHEMBL2199441 | 0.79 | ODC1 (0.36) | KDM4E | |
| SCHEMBL4618155 | 0.75 | MEN1 (0.38) | KDM4E | |
| SCHEMBL2994453 | 0.75 | GRIK1 (0.31) | TET2 | |
| SCHEMBL6576734 | 0.74 | FDPS (0.39) | — | |
| SCHEMBL6446033 | 0.74 | FDPS (0.36) | — | |
| SCHEMBL2991692 | 0.72 | — | — | |
| SCHEMBL6448587 | 0.72 | FDPS (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2519692-B1 | PROCESS TO ENHANCING DRY STRENGTH OF PAPER BY TREATMENT WITH VINYLAMINE-CONTAINING POLYMERS AND ACRYLAMIDE CONTAINING POLYMERS | SOLENIS TECHNOLOGIES CAYMAN LP (CH) | 2017-03-15 | — | — | EP | claimed |
| US-8673988-B2 | Graft copolymers for ion exchange chromatography | MERCK PATENT GMBH (DE) | 2014-03-18 | — | — | US | claimed |
| US-8636875-B2 | Enhanced dry strength and drainage performance by combining glyoxalated acrylamide-containing polymers with cationic aqueous dispersion polymers | HERCULES INCORPORATED (US) | 2014-01-28 | — | — | US | claimed |
| WO-2006110540-A2 | ANTIMICROBIAL POLYMER COATINGS AND A METHOD PRODUCING THEM VIA CHEMICAL VAPOUR DEPOSITION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-10-19 | — | — | WO | claimed |
| US-20060228966-A1 | Chemical vapor deposition of antimicrobial polymer coatings | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-10-12 | — | — | US | claimed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| EP-2310104-B1 | MIXED GRAFT POLYMERS FOR ION EXCHANGE CHROMATOGRAPHY | MERCK PATENT GMBH (DE) | 2017-10-18 | — | — | EP | disclosed |
| EP-2285485-B1 | CE(IV)-INITIATED GRAFT POLYMERIZATION ON POLYMERS NOT CONTAINING HYDROXYL GROUPS | MERCK PATENT GMBH (DE) | 2014-04-23 | — | — | EP | disclosed |
| US-8673988-B2 | Graft copolymers for ion exchange chromatography | MERCK PATENT GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20120295992-A1 | Ce(IV)-INITIATED GRAFT POLYMERISATION ON POLYMERS CONTAINING NO HYDROXYL GROUPS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2012-11-22 | — | — | US | disclosed |
| US-20110136925-A1 | GRAFT COPOLYMERS FOR ION EXCHANGE CHROMATOGRAPHY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-06-09 | — | — | US | disclosed |
| EP-2310104-A1 | GRAFT COPOLYMERS FOR ION EXCHANGE CHROMATOGRAPHY | Merck Patent GmbH (DE) | 2011-04-20 | — | — | EP | disclosed |
| EP-2285485-A1 | CE(IV)-INITIATED GRAFT POLYMERIZATION ON POLYMERS NOT CONTAINING HYDROXYL GROUPS | Merck Patent GmbH (DE) | 2011-02-23 | — | — | EP | disclosed |
| US-20100303877-A1 | Controlled Release Hydrogel Films | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-12-02 | — | — | US | disclosed |
| EP-2153877-A1 | Mixed graft polymers for ion exchange chromatography | MERCK PATENT GmbH (DE) | 2010-02-17 | — | — | EP | disclosed |
| WO-2010012358-A1 | GRAFT COPOLYMERS FOR ION EXCHANGE CHROMATOGRAPHY | MERCK PATENT GMBH (DE) | 2010-02-04 | — | — | WO | disclosed |
| WO-2009143953-A1 | CE(IV)-INITIATED GRAFT POLYMERIZATION ON POLYMERS NOT CONTAINING HYDROXYL GROUPS | MERCK PATENT GMBH (DE) | 2009-12-03 | — | — | WO | disclosed |
| US-7563734-B2 | Chemical vapor deposition of antimicrobial polymer coatings | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-07-21 | — | — | US | disclosed |
| WO-2006110540-A2 | ANTIMICROBIAL POLYMER COATINGS AND A METHOD PRODUCING THEM VIA CHEMICAL VAPOUR DEPOSITION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-10-19 | — | — | WO | disclosed |
| US-20060228966-A1 | Chemical vapor deposition of antimicrobial polymer coatings | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295992-A1 | Ce(IV)-INITIATED GRAFT POLYMERISATION ON POLYMERS CONTAINING NO HYDROXYL GROUPS | CCR4, CES2, HLA-C | KDM4E 873/4885TET2 1050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.